Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Doyne honeycomb retinal dystrophy


Other Names for this Disease

  • DHD
  • DHRD
  • Doyne honeycomb degeneration of retina
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Newline Maker

How might Doyne honeycomb retinal dystrophy (DHRD) be treated?

There is currently no cure for Doyne honeycomb retinal dystrophy (DHRD) and treatment options are limited. Management of hereditary retinal dystrophies generally focuses on vision rehabilitation, which involves the use of low vision aids, orientation, and mobility training. The goal of visual rehabilitation is to reach maximum function, a sense of well being, a personally satisfying level of independence, and optimum quality of life.[1][2]

Choroidal neovascularization (CNV), the growth of new blood vessels in the choroid, can develop in people with DHRD and has a poor visual prognosis. The authors of a 2011 study reported that 2 people with DHRD and CNV were treated with a course of intravitreal bevacizumab (injected into the eye). This treatment stopped fluid leakage and led to increased visual acuity. They proposed that recovery of visual acuity after treatment of CNV in these cases shows that the loss of retinal function may be reversible. However, this finding needs to be confirmed in more studies with a larger number of participants.[3]

There was also a case report of a person with malattia leventinese (a condition very similar to DHRD and sometimes considered the same) who was treated successfully with photodynamic therapy using verteporfin. The treatment reportedly prevented severe visual loss in the patient. The authors of this case report proposed that photodynamic therapy be considered as a possible treatment in patients with malattia leventinese or DHRD who develop CNV.[4]
 
You may consider participating in a clinical trial for treatment of retinal dystrophy. The U.S. National Institutes of Health, through the National Library of Medicine, developed ClinicalTrials.gov to provide patients, family members, and members of the public with current information on clinical research studies. 

There are many clinical trials currently enrolling individuals with hereditary retinal dystrophy. View a list of these studies here. After you click on a study, review its eligibility criteria to determine its appropriateness. We suggest reviewing the list of studies with your physician. Use the study’s contact information to learn more. You can check this site often for regular updates. Use "retinal dystrophy" or "Doyne honeycomb retinal dystrophy" as your search term.
Last updated: 7/25/2014

References
  1. Patient.co.uk. Hereditary Retinal Dystrophies. Last reviewed: 05/23/2011; http://www.patient.co.uk/doctor/Hereditary-Retinal-Dystrophies.htm. Accessed 7/25/2014.
  2. American Optometric Association. Definition of Vision Rehabilitation. 06/2004; http://www.aoa.org/optometrists/membership/aoa-sections/vision-rehabilitation-section/membership-benefits/definition-of-vision-rehabilitation?sso=y. Accessed 7/25/2014.
  3. Sohn EH, Patel PJ, MacLaren RE, Adatia FA, Pal B, Webster AR, Tufail A. Responsiveness of choroidal neovascular membranes in patients with R345W mutation in fibulin 3 (Doyne honeycomb retinal dystrophy) to anti-vascular endothelial growth factor therapy. Arch Ophthalmol. December, 2011; 129(12):1626-1628. Accessed 10/22/2014.
  4. Dantas MA, Slakter JS, Negrao S et al. Photodynamic therapy with verteporfin in mallatia leventinese. Ophthalmology. February, 2002; 109(2):296-301. http://www.ncbi.nlm.nih.gov/pubmed/11825812. Accessed 7/25/2014.


Other Names for this Disease
  • DHD
  • DHRD
  • Doyne honeycomb degeneration of retina
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.